Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-129
Closed -$48.2K – 840
2024
Q2
$48.2K Buy
129
+88
+215% +$29.7K 0.01% 375
2024
Q1
$14.2K Buy
+41
New +$15.5K ﹤0.01% 559
2023
Q3
– Sell
-13
Closed -$5.81K – 734
2023
Q2
$5.81K Sell
13
-78
-86% -$39.3K ﹤0.01% 446
2023
Q1
$44.2K Sell
91
-4
-4% -$1.98K 0.01% 321
2022
Q4
$48.7K Sell
95
-50
-34% -$26.3K 0.01% 306
2022
Q3
$70K Buy
145
+19
+15% +$9.24K 0.01% 273
2022
Q2
$59K Buy
+126
New +$56.1K 0.01% 271
2020
Q4
– Sell
-18
Closed -$7K – 546
2020
Q3
$7K Buy
+18
New +$7.24K ﹤0.01% 298

Other funds holding HUM

Crewe Advisors's HUM Position: Q3 2024 in Review

Crewe Advisors sold out of Humana (HUM) in Q3 2024, closing a stake of 129 shares — an estimated $48.2K sold.

Crewe Advisors first reported a position in HUM in Q3 2020 and held it in 8 quarters. The position peaked at $70K in Q3 2022. 941 funds tracked by Wall St. Rank hold HUM as of Q3 2024.

  • Crewe Advisors reported no remaining Humana position as of Q3 2024 after selling out during the quarter.
  • Crewe Advisors sold 129 Humana shares in Q3 2024, an estimated $48.2K.
  • Crewe Advisors first reported a position in Humana in Q3 2020 and held it in 8 quarters.
  • Crewe Advisors's Humana position peaked at $70K in Q3 2022.
  • 941 funds tracked by Wall St. Rank held Humana as of Q3 2024.

Based on Crewe Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.